ACET · Company research
Adicet Bio, Inc. (ACET): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
15records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| A new hire waits a year to gain the right to buy Adicet shares - Stock Titan | A new hire waits a year to gain the right to buy Adicet shares Stock Titan | View source ↗ | Stock Titan | Sep 30, 2026 | neutral | 0 | 0.6 |
| Adicet Bio, Inc. (ACET) Discusses Positive Prula-cel Data and Plans for Pivotal Study in Lupus Nephritis - Slideshow - Seeking Alpha | Adicet Bio, Inc. (ACET) Discusses Positive Prula-cel Data and Plans for Pivotal Study in Lupus Nephritis - Slideshow Seeking Alpha | View source ↗ | Seeking Alpha | Sep 30, 2026 | neutral | 0 | 0.6 |
| Adicet Bio (NASDAQ:ACET) Stock Gets Price Target Boost from HC Wainwright - MarketBeat | Adicet Bio (NASDAQ:ACET) Stock Gets Price Target Boost from HC Wainwright MarketBeat | View source ↗ | MarketBeat | Sep 28, 2026 | neutral | 0 | 0.6 |
| Adicet Bio (NasdaqCM:ACET) Stock Forecast & Analyst Predictions - Simply Wall Street | Adicet Bio (NasdaqCM:ACET) Stock Forecast & Analyst Predictions Simply Wall Street | View source ↗ | Simply Wall Street | Sep 28, 2026 | neutral | 0 | 0.6 |
| Every patient in Adicet's lupus study stopped immune-suppressing drugs - Stock Titan | Every patient in Adicet's lupus study stopped immune-suppressing drugs Stock Titan | View source ↗ | Stock Titan | Sep 28, 2026 | neutral | 0 | 0.6 |
| Adicet Bio (Nasdaq:ACET) - Stock Analysis - Simply Wall Street | Adicet Bio (Nasdaq:ACET) - Stock Analysis Simply Wall Street | View source ↗ | Simply Wall Street | Sep 28, 2026 | neutral | 0 | 0.6 |
| Adicet Bio (NASDAQ:ACET) Stock Moved Up to "Hold" by Wall Street Zen - MarketBeat | Adicet Bio (NASDAQ:ACET) Stock Moved Up to "Hold" by Wall Street Zen MarketBeat | View source ↗ | MarketBeat | Sep 26, 2026 | neutral | 0 | 0.6 |
| Data on a possible lupus treatment are due Monday - Stock Titan | Data on a possible lupus treatment are due Monday Stock Titan | View source ↗ | Stock Titan | Sep 25, 2026 | neutral | 0 | 0.6 |
| Adicet Bio (NASDAQ:ACET) Stock Passes Above Two Hundred Day Moving Average - Time to Sell? - MarketBeat | Adicet Bio (NASDAQ:ACET) Stock Passes Above Two Hundred Day Moving Average - Time to Sell? MarketBeat | View source ↗ | MarketBeat | Sep 11, 2026 | neutral | 0 | 0.6 |
| FDA clears Adicet Bio's application to study a gene-edited prostate cancer therapy - Stock Titan | FDA clears Adicet Bio's application to study a gene-edited prostate cancer therapy Stock Titan | View source ↗ | Stock Titan | Aug 27, 2026 | neutral | 0 | 0.6 |
| Here's Why You Should Add ACET Stock to Your Portfolio Now - Yahoo Finance | Here's Why You Should Add ACET Stock to Your Portfolio Now Yahoo Finance | View source ↗ | Yahoo Finance | Aug 24, 2026 | neutral | 0 | 0.6 |
| Are Medical Stocks Lagging Adicet Bio (ACET) This Year? - Yahoo Finance | Are Medical Stocks Lagging Adicet Bio (ACET) This Year? Yahoo Finance | View source ↗ | Yahoo Finance | Aug 18, 2026 | neutral | 0 | 0.6 |
| Wall Street Analysts Think Adicet Bio (ACET) Could Surge 301.57%: Read This Before Placing a Bet - Yahoo Finance | Wall Street Analysts Think Adicet Bio (ACET) Could Surge 301.57%: Read This Before Placing a Bet Yahoo Finance | View source ↗ | Yahoo Finance | Aug 14, 2026 | neutral | 0 | 0.6 |
| Is Adicet Bio (ACET) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance | Is Adicet Bio (ACET) Stock Outpacing Its Medical Peers This Year? Yahoo Finance | View source ↗ | Yahoo Finance | Jul 1, 2026 | neutral | 0 | 0.6 |
| ACET Forecast — Price Target — Prediction for 2027 - TradingView | ACET Forecast — Price Target — Prediction for 2027 TradingView | View source ↗ | TradingView | Jun 26, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.